Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.

Title: Validation of the BOADICEA model in a prospective cohort of BRCA1/2 pathogenic variant carriers.
Authors: Yang,Xin; Mooij,Thea M; Leslie,Goska; Ficorella,Lorenzo; Andrieu,Nadine; Kast,Karin; Singer,Christian F; Jakubowska,Anna; van Gils, Carla H; Tan,Yen Y; Engel,Christoph; Adank,Muriel A; van Asperen,Christi J; Ausems, Margreet G E M; Berthet,Pascaline; Collee,Margriet J; Cook,Jackie A; Eason,Jacqueline; Spaendonck-Zwarts,Karin Y van; Evans,D Gareth; Gómez García,Encarna B; Hanson,Helen; Izatt,Louise; Kemp,Zoe; Lalloo,Fiona; Lasset,Christine; Lesueur,Fabienne; Musgrave,Hannah; Nambot,Sophie; Noguès,Catherine; Oosterwijk,Jan C; Stoppa-Lyonnet,Dominique; Tischkowitz,Marc; Tripathi,Vishakha; Wevers, Marijke R; Zhao,Emily; van Leeuwen,Flora E; Schmidt,Marjanka K; Easton,Douglas F; Rookus,Matti A; Antoniou,Antonis C; EMBRACE Collaborators; Epi Kanker Team A; Cancer; JC onderzoeksprogramma Cancer; Genetica Klinische Genetica
Publication Year: 2024
Subject Terms: Early Diagnosis; Genetic Counseling; Public Health; Women's Health; Genetics(clinical); Genetics; Journal Article
Description: Background: No validation has been conducted for the BOADICEA multifactorial breast cancer risk prediction model specifically in BRCA1/2 pathogenic variant (PV) carriers to date. Here, we evaluated the performance of BOADICEA in predicting 5-year breast cancer risks in a prospective cohort of BRCA1/2 PV carriers ascertained through clinical genetic centres. Methods: We evaluated the model calibration and discriminatory ability in the prospective TRANsIBCCS cohort study comprising 1614 BRCA1 and 1365 BRCA2 PV carriers (209 incident cases). Study participants had lifestyle, reproductive, hormonal, anthropometric risk factor information, a polygenic risk score based on 313 SNPs and family history information. Results: The full multifactorial model considering family history together with all other risk factors was well calibrated overall (E/O=1.07, 95% CI: 0.92 to 1.24) and in quintiles of predicted risk. Discrimination was maximised when all risk factors were considered (Harrell's C-index=0.70, 95% CI: 0.67 to 0.74; area under the curve=0.79, 95% CI: 0.76 to 0.82). The model performance was similar when evaluated separately in BRCA1 or BRCA2 PV carriers. The full model identified 5.8%, 12.9% and 24.0% of BRCA1/2 PV carriers with 5-year breast cancer risks of
Document Type: article in journal/newspaper
File Description: text/plain
Language: English
ISSN: 0022-2593
Relation: https://dspace.library.uu.nl/handle/1874/454622
Availability: https://dspace.library.uu.nl/handle/1874/454622
Rights: info:eu-repo/semantics/OpenAccess
Accession Number: edsbas.A67E0B59
Database: BASE